Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-20

Clinical Trial Update: Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML [Phase 2]

View source ↗

Summary

Phase 2 trial update for elderly patients with untreated acute myeloid leukemia evaluating Veneclax and Chidaniline with Azacitidine, followed by Decitabine plu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZACITIDINE (AZACITIDINE)
  • Chidaniline
  • Decitabine (Decitabine)
  • Veneclax

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING